This is a demo version of PatientsMap database.
The demo version shows only GERD.
% of physicians treating each disease by specialty
Gastroenterological diseases |
-- |
Cardiovascular disease |
-- |
Endocrine disease |
-- |
Hematologic disease |
-- |
Respiratory system disease |
-- |
Central nerves system |
-- |
Psychiatric disease |
-- |
Cancer/Malignant tumor/Cancer pain |
-- |
Orthopedic disease |
-- |
Gynecologic disease |
-- |
Urinary system disease |
-- |
Ophthalmologic disease |
-- |
Otorhinolaryngological disease |
-- |
Dermatological disease |
-- |
Rare disease - 1 |
-- |
Rare disease - 2 |
-- |
Rare disease - 3 |
-- |
Rare disease - 4 |
-- |
Distribution of physicians by number of patients / Summary/ Patient flow projection
Gastroenterological diseases
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
GERD/NERD |
2 |
-- |
-NERD only |
3 |
-- |
Gastritis and duodenitis |
4 |
-- |
Functional Dyspepsia (FD) |
5 |
-- |
Peptic ulcer |
6 |
-- |
Cirrhosis |
7 |
-- |
-Compensated cirrhosis due to hepatitis C |
8 |
-- |
Chronic hepatitis C |
9 |
-- |
Chronic hepatitis B |
10 |
-- |
Non-alcoholic steatohepatitis (NASH) |
11 |
-- |
Pancreatitis |
12 |
-- |
Irritable Bowel Syndrome (IBS) |
13 |
-- |
Ulcerative colitis |
14 |
-- |
Crohn's disease |
15 |
-- |
Acute enteritis |
16 |
-- |
Inflammatory Bowel Disease (IBD) |
17 |
-- |
Constipation |
18 |
-- |
Hemorrhoids |
19 |
-- |
Cystic Fibrosis (CF) |
20 |
-- |
Intraperitoneal infections disease |
21 |
-- |
Rotavirus gastroenteritis |
22 |
-- |
Cardiovascular disease
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Hypertension |
24 |
-- |
Pulmonary hypertension |
25 |
-- |
-Plumonary arterial hypertension |
26 |
-- |
Myocardial Infarction (MI) |
27 |
-- |
-Old Myocardial Infarction (OMI) |
28 |
-- |
-Acute Myocardial Infarction(AMI) |
29 |
-- |
Acute heart failure |
30 |
-- |
Chronic heart failure |
31 |
-- |
Stable angina |
32 |
-- |
Unstable angina |
33 |
-- |
Tachyarrhythmia |
34 |
-- |
-Atrial fibrillation |
35 |
-- |
Bradyarrhythmia |
36 |
-- |
Arteriosclerosis obliterans (ASO) |
37 |
-- |
Deep-vein thrombosis (DVT) |
38 |
-- |
Pulmonary Embolism (PE) |
39 |
-- |
Postoperative venous thromboembolism |
40 |
-- |
Peripheral Arterial Disease (PAD) |
41 |
-- |
Cardiac edema |
42 |
-- |
Hepatic edema |
43 |
-- |
Infective endocarditis |
44 |
-- |
Atherosclerosis |
45 |
-- |
Cardiomyopathy |
46 |
-- |
Endocrine disease
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Dyslipidemia/ Hyperlipidemia |
48 |
-- |
-Hypertriglyceridemia |
49 |
-- |
Diabetes |
50 |
-- |
-Type I diabetes |
51 |
-- |
-Type II diabetes |
52 |
-- |
Diabetic neuropathy |
53 |
-- |
-Diabetic neuropathic pain |
54 |
-- |
Diabetic nephropathy |
55 |
-- |
Diabetes with peripheral circulatory disorders |
56 |
-- |
Obesity |
57 |
-- |
-Obesity induced by antipsychotic |
58 |
-- |
Gout/ Hyperuricemia |
59 |
-- |
Pituitary dwarfism |
60 |
-- |
Hematologic disease
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Sepsis |
62 |
-- |
AIDS / HIV carrier |
63 |
-- |
Thrombocytopenia |
64 |
-- |
-Idiopathic thrombocytopenic purpura |
65 |
-- |
Febrile neutropenia |
66 |
-- |
Hypoalbuminemia |
67 |
-- |
Disseminated intravascular coagulation (DIC) |
68 |
-- |
Hemophilia A |
69 |
-- |
Hemophilia B |
70 |
-- |
Respiratory system disease
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Bronchial asthma |
72 |
-- |
-Infantile bronchial asthma |
73 |
-- |
-Adult bronchial asthma |
74 |
-- |
COPD/Emphysema |
75 |
-- |
Chronic bronchitis |
76 |
-- |
Acute upper respiratory tract infection |
77 |
-- |
Acute lower respiratory tract infection |
78 |
-- |
Pneumonia |
79 |
-- |
-Nosocomial pneumonia |
80 |
-- |
-Community-acquired pneumonia |
81 |
-- |
-Nursing and healthcare associated pneumonia (NHCAP) |
82 |
-- |
Pulmonary tuberculosis |
83 |
-- |
MRSA infection |
84 |
-- |
Candidiasis |
85 |
-- |
Measles, Rubella |
86 |
-- |
Central nerves system
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Cerebral hemorrhage incl. (subarachnoid) |
88 |
-- |
Cerebral infarction |
89 |
-- |
-Acute phase cerebral thrombosis |
90 |
-- |
Mild Cognitive Impairment(MCI) |
91 |
-- |
Dementia |
92 |
-- |
-Alzheimer's dementia |
93 |
-- |
-Vascular-type dementia |
94 |
-- |
-Dementia with Lewy Bodies (DLB) |
95 |
-- |
iNPH |
96 |
-- |
sNPH |
97 |
-- |
Infantile hydrocepharlus |
98 |
-- |
Other hydrocepharlus |
99 |
-- |
Headache |
100 |
-- |
-Migraine |
101 |
-- |
-Cluster headache |
102 |
-- |
Epilepsia |
103 |
-- |
Parkinson's disease |
104 |
-- |
Meniere's disease |
105 |
-- |
Dizziness |
106 |
-- |
Fibromyalgia |
107 |
-- |
Neuropathy (non-diabetic) |
108 |
-- |
Trigeminal neuralgia |
109 |
-- |
Postherpetic neuralgia (PHN) |
110 |
-- |
Autonomic imbalance |
111 |
-- |
Multiple sclerosis |
112 |
-- |
-Relapsing-remitting multiple sclerosis |
113 |
-- |
-Primary progressive multiple sclerosis |
114 |
-- |
-Secondary progressive multiple sclerosis |
115 |
-- |
-Neuromyelitis Optica (NMO) |
116 |
-- |
Neuromuscular disorder and myopathy |
117 |
-- |
Restless leg syndrome (RLS) |
118 |
-- |
Spasmodic torticollis |
119 |
-- |
Myasthenia gravis |
120 |
-- |
Psychiatric disease
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Schizophrenia |
122 |
-- |
Depression |
123 |
-- |
-Major depression |
124 |
-- |
-Neurotic depression |
125 |
-- |
-Treatment-resistant depression |
126 |
-- |
-Psychotic depression |
127 |
-- |
Bipolar disorder |
128 |
-- |
Anxiety disorder |
129 |
-- |
Generalized Anxiety Disorder (GAD) |
130 |
-- |
Social anxiety disorder (SAD) |
131 |
-- |
Panic Disorder (PD) |
132 |
-- |
Obsessive-Compulsive Disorder (OCD) |
133 |
-- |
Posttraumatic stress disorder(PTSD) |
134 |
-- |
Attention Deficit Hyperactivity Disorder |
135 |
-- |
Eating disorder |
136 |
-- |
-Bulimia |
137 |
-- |
-Anorexia nervosa |
138 |
-- |
Sleep disorder |
139 |
-- |
-Insomnia |
140 |
-- |
-Nocturnal enuresis |
141 |
-- |
-Obstructive sleep apnea syndrome |
142 |
-- |
Alcohol dependence |
143 |
-- |
Drug dependence |
144 |
-- |
Cancer/Malignant tumor/Cancer pain
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Brain tumor (all kinds including glioma) |
146 |
-- |
-Malignant glioma |
147 |
-- |
Head and neck cancer |
148 |
-- |
-Oral cancer |
149 |
-- |
-Nasopharyngeal cancer |
150 |
-- |
-Oropharyngeal cancer |
151 |
-- |
-Hypopharyngeal cancer |
152 |
-- |
-Laryngeal cancer |
153 |
-- |
-Paranasal sinus and nasal cavity cancer |
154 |
-- |
Esophageal cancer |
155 |
-- |
Small Cell Lung Cancer (SCLC) |
156 |
-- |
Non-small cell lung cancer |
157 |
-- |
Pleura malignant mesothelioma |
158 |
-- |
Stomach (gastric) cancer |
159 |
-- |
Stomach MALT lymphoma |
160 |
-- |
Gastrointestinal stromal tumor (GIST) |
161 |
-- |
Neuroendocrine tumor (NET) |
162 |
-- |
-Neuroendocrine tumors of the gastrointestinal tract |
163 |
-- |
-Pancreas neuroendocrine tumor |
164 |
-- |
Basal cell carcinoma (BCC) |
165 |
-- |
Colon cancer |
166 |
-- |
Rectum cancer |
167 |
-- |
Hepatocellular carcinoma |
168 |
-- |
Cholangiocellular carcinoma (CCC) |
169 |
-- |
Pancreatic cancer |
170 |
-- |
Renal cell carcinoma |
171 |
-- |
Breast cancer |
172 |
-- |
HER2 positive breast cancer |
173 |
-- |
Premenopausal breast cancer |
174 |
-- |
Ovarian cancer |
175 |
-- |
Endometrial cancer |
176 |
-- |
Cervical cancer |
177 |
-- |
Prostate cancer |
178 |
-- |
Hormone refractory prostate cancer (HRPC) |
179 |
-- |
Bladder cancer |
180 |
-- |
Malignant melanoma |
181 |
-- |
Soft tissue sarcoma |
182 |
-- |
Acute myelogenous leukemia (AML) |
183 |
-- |
Acute lymphocytic leukemia(ALL) |
184 |
-- |
ChronicMyelogenousLeukemia(CML) |
185 |
-- |
-Polycythemia vera(PV) |
186 |
-- |
Aplastic anemia |
187 |
-- |
Myelodysplastic syndrom |
188 |
-- |
Idiopathic myelofibrosis |
189 |
-- |
Essential thrombocythemia |
190 |
-- |
Secondary myelofibrosis |
191 |
-- |
Chronic lymphocytic leukemia |
192 |
-- |
-B-cell chronic lymphocytic leukemia(B-CLL) |
193 |
-- |
Hodgkin's lymphoma |
194 |
-- |
Non-Hodgkin's lymphoma |
195 |
-- |
-Systemic anaplastic large cell lymphoma (sALCL) |
196 |
-- |
-Cutaneous T-cell lymphoma (CTCL) |
197 |
-- |
-Peripheral T-cell lymphoma (PTCL) |
198 |
-- |
-Diffuse large B-cell lymphoma |
199 |
-- |
-Follicular lymphoma |
200 |
-- |
Multiple myeloma (MM) |
201 |
-- |
Graft versus host disease: GVHD |
202 |
-- |
Cancer pain |
203 |
-- |
-Breakthrough pain |
204 |
-- |
Carcinomatous anemia |
205 |
-- |
Cases of bone angiogenesis |
206 |
-- |
Cases of bone metastasis |
207 |
-- |
Cachexia |
208 |
-- |
Orthopedic disease
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Rheumatoid arthritis |
210 |
-- |
Juvenile Rheumatoid Arthritis (JRA) |
211 |
-- |
Ankylosing spondylitis |
212 |
-- |
Lumbar (intervertebral) disc disorder |
213 |
-- |
Lumbar disc herniation |
214 |
-- |
Lumbar spinal stenosis |
215 |
-- |
Osteoarthritis |
216 |
-- |
Knee osteoarthritis |
217 |
-- |
Hip osteoarthritis |
218 |
-- |
Shoulder osteoarthritis |
219 |
-- |
Spondylosis |
220 |
-- |
Low back pain |
221 |
-- |
Osteoporosis |
222 |
-- |
Amyotrophic Lateral Sclerosis (ALS) |
223 |
-- |
Periarthritis Humeroscapularis |
224 |
-- |
Dupuytren's contracture |
225 |
-- |
Degenerative intervertebral discs |
226 |
-- |
Osteochondral defect |
227 |
-- |
Shoulder-Hand syndrome |
228 |
-- |
Enthesopathy |
229 |
-- |
Carpal tunnel syndrome |
230 |
-- |
Cervical disc hernia |
231 |
-- |
Gynecologic disease
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Uterine fibroids |
233 |
-- |
Endometriosis |
234 |
-- |
Menopausal symptoms |
235 |
-- |
Dysmenorrhea |
236 |
-- |
Menstrual disorder |
237 |
-- |
Hypermenorrhea |
238 |
-- |
Dysfunctional metrorrhagia |
239 |
-- |
Toxemia of pregnancy |
240 |
-- |
Polycystic ovary syndrome |
241 |
-- |
Urinary system disease
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Nephrotic syndrome |
243 |
-- |
Chronic glomerulonephritis |
244 |
-- |
Chronic renal failure (with dialysis) |
245 |
-- |
-Hyperphosphatemia |
246 |
-- |
-Hyperparathyroidism |
247 |
-- |
-On peritoneal dialysis |
248 |
-- |
Chronic renal failure (without dialysis) |
249 |
-- |
Renal anemia |
250 |
-- |
Kidney stone |
251 |
-- |
Urethral stone |
252 |
-- |
Benign Prostatic Hypertrophy (BPH) |
253 |
-- |
-Dysuria with Benign Prostatic Hypertrophy (BPH) |
254 |
-- |
Overactive bladder (OAB) |
255 |
-- |
Neurogenic Bladder (NB) |
256 |
-- |
Erectile Dysfunction (ED) |
257 |
-- |
Peyronie's disease |
258 |
-- |
Herpes progenitalis |
259 |
-- |
Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
260 |
-- |
Chlamydial infection |
261 |
-- |
Pyelonephritis |
262 |
-- |
Cystitis |
263 |
-- |
-Cystitis interstitial |
264 |
-- |
Urethritis |
265 |
-- |
Urinary incontinence |
266 |
-- |
Chronic prostatitis |
267 |
-- |
Ophthalmologic disease
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Diabetic retinopathy |
269 |
-- |
Diabetic macular edema |
270 |
-- |
Diabetic keratopathy |
271 |
-- |
Glaucoma |
272 |
-- |
Ocular hypertension |
273 |
-- |
Cataract |
274 |
-- |
Age-related macular degeneration (AMD) |
275 |
-- |
-Exudative age-related macular degeneration |
276 |
-- |
Infectious conjunctivitis |
277 |
-- |
Conjunctivitis |
278 |
-- |
Dry eye |
279 |
-- |
Corneal epithelium disorder |
280 |
-- |
Persistent Ectocornea Defect (PED) |
281 |
-- |
Blepharospasm |
282 |
-- |
Central retinal vein occlusion (CRVO) |
283 |
-- |
Branch retinal vein occlusion (BRVO) |
284 |
-- |
Otorhinolaryngological disease
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Perennial allergic rhinitis |
286 |
-- |
Seasonal allergic rhinitis/Hay fever |
287 |
-- |
Hypoacusis (hearing loss) |
288 |
-- |
-Sudden deafness |
289 |
-- |
Acute paranasal sinusitis |
290 |
-- |
Chronic sinus infection |
291 |
-- |
Taste disorder |
292 |
-- |
Dermatological disease
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Atopic dermatitis |
294 |
-- |
Hives |
295 |
-- |
Pruritus |
296 |
-- |
Psoriasis |
297 |
-- |
-Psoriasis vulgaris |
298 |
-- |
-Psoriasis arthropica |
299 |
-- |
Herpes labialis |
300 |
-- |
Herpes zoster |
301 |
-- |
Androgenic alopecia (AGA) |
302 |
-- |
Acne vulgaris (acne) |
303 |
-- |
Foot fungus/ Nail fungus |
304 |
-- |
Dermatophytosis (ringworm/ tinea) |
305 |
-- |
Bedsore |
306 |
-- |
cSSSI being caused gram-positive bacterium |
307 |
-- |
Polymyositis/Dermatomyositis |
308 |
-- |
Systemic scleroderma |
309 |
-- |
Maschalyperidrosis |
310 |
-- |
Rare disease
Disease |
CODE |
Cross Tabulation |
Summary |
Nationwide Projection |
Spinocerebellar degeneration |
315 |
-- |
Shy-Drager syndrome |
316 |
-- |
Moyamoya disease |
317 |
-- |
Guillain-Barre syndrome |
318 |
-- |
Fisher's syndrome |
319 |
-- |
Chronic Inflammatory Demyelinating Polyneuropathy |
320 |
-- |
Multifocal motor neuropathy |
321 |
-- |
Peripheral neuritis with Mab |
322 |
-- |
Spinal muscular atrophy (SMA) |
323 |
-- |
Spinal and bulbar muscular atrophy (SBMA) |
324 |
-- |
Syringomyelia |
325 |
-- |
Huntington disease |
326 |
-- |
Progressive supranuclear palsy |
327 |
-- |
Striatonigral degeneration (SND) |
328 |
-- |
Peroxisomal disorder |
329 |
-- |
Lysosomal storage diseases |
330 |
-- |
-Mucopolysaccharidosis (MPS) I |
331 |
-- |
-Mucopolysaccharidosis (MPS) II |
332 |
-- |
-Gaucher's disease |
333 |
-- |
-Fabry disease |
334 |
-- |
-Pompe disease |
335 |
-- |
Creuzfeldt-Jakob Disease (CJD) |
336 |
-- |
Gerstmann-Straussler-Sheinker syndrome |
337 |
-- |
Fatal familial insomnia |
338 |
-- |
Subacute sclerosing panencephalitis (SSPE) |
339 |
-- |
Progressive Multifocal Leukoencephalopathy |
340 |
-- |
Ossification of posterior longitudinal Ligament |
341 |
-- |
Ossification of the ligamentum flavum |
342 |
-- |
Ossification of anterior longitudinal ligament |
343 |
-- |
Disseminated spinal canal stenosis |
344 |
-- |
Idiopathic necrosis of the femoral head |
345 |
-- |
Idiopathic steroidal osteonecrosis |
346 |
-- |
Retinitis pigmentosa |
347 |
-- |
Refractory optic neuropathy |
348 |
-- |
Idiopathic bilaterally sensorineural deafness |
349 |
-- |
Delayed endolymphatic hydrops |
350 |
-- |
Syndrome of abnormal secretion of prolactin |
351 |
-- |
Syndrome of abnormal secretion of gonadotropin |
352 |
-- |
Syndrome of abnormal secretion of antidiuretic hormone |
353 |
-- |
Central eating disorder |
354 |
-- |
Primary aldosteronism |
355 |
-- |
Pseudohypoaldosteronism |
356 |
-- |
Glucocorticoid resistance syndrome |
357 |
-- |
Adrenal enzyme deletion |
358 |
-- |
Adrenal hypoplasia |
359 |
-- |
Pseudohypoparathyroidism |
360 |
-- |
Syndrome of abnormal vitamin D receptor |
361 |
-- |
Syndrome of abnormal recepter of TSH |
362 |
-- |
Thyroid hormone resistance syndrome |
363 |
-- |
Hemolytic anemia |
364 |
-- |
Refractory anemia |
365 |
-- |
Idiopathic thrombosis |
366 |
-- |
Thrombotic thrombocytopenic purpura (TTP) |
367 |
-- |
IgA nephropathy |
368 |
-- |
Rapidly progressive glomerulonephritis |
369 |
-- |
Refractory nephrotic syndorme |
370 |
-- |
Polycystic kidney |
371 |
-- |
Hypertrophic cardiomyopathy |
372 |
-- |
Dilated cardiomyopathy |
373 |
-- |
Restrictive cardiomyopathy |
374 |
-- |
Familial sudden death syndrome |
375 |
-- |
Primary hyperlipidemia |
376 |
-- |
Familial hypercholesterolemia |
377 |
-- |
Idiopathic interstitial pneumonia |
378 |
-- |
Sarcoidosis |
379 |
-- |
Diffuse panbronchiolitis (DPB) |
380 |
-- |
Autoimmune hepatitis |
381 |
-- |
Primary biliary cirrhosis |
382 |
-- |
Fluminant hepatitis |
383 |
-- |
Idiopathic portal hypertension (IPH) |
384 |
-- |
Extrahepahc portal obstruction |
385 |
-- |
Budd-Chiari syndrome |
386 |
-- |
Intrahepatic lithiasis |
387 |
-- |
Intrahepatic bile duct disease |
388 |
-- |
Cystic fibrosis |
389 |
-- |
Severe acute pancreatitis |
390 |
-- |
Chronic pancreatitis |
391 |
-- |
Amyloidosis |
392 |
-- |
Behcet disease |
393 |
-- |
Systemic Lupus Erythematosus (SLE) |
394 |
-- |
-Lupus nephritis |
395 |
-- |
Sjogren's syndrome |
396 |
-- |
Adult Still's Disease (ASD) |
397 |
-- |
Takayasu's disease (aortitis syndrome) |
398 |
-- |
Buerger disease |
399 |
-- |
Polyarteritis nodosa |
400 |
-- |
Malignant rheumatoid arthritis (rheumatoid vasculitis) |
401 |
-- |
Temporal arteritis |
402 |
-- |
Anti-phospholipid antibody syndrome (APS) |
403 |
-- |
Eosinophilic fasciitis |
404 |
-- |
Lichen sclerosus et atrophicus |
405 |
-- |
Primary immunodeficiency syndrome |
406 |
-- |
Juvenile emphysema |
407 |
-- |
Langerhans-Cell Histiocytosis (LCH) |
408 |
-- |
Obesity Hypoventilation Syndrome (OHS) |
409 |
-- |
Alveolar hypoventilation syndrome |
410 |
-- |
Idiopathic chronic pulmonary thromboembolism w/ pulmonary HTN |
411 |
-- |
Mixed connective-tissue disease |
412 |
-- |
Neurofibromatosis type 1 (Recklinghausen's disease) |
413 |
-- |
Neurofibromatosis type 2 |
414 |
-- |
Tuberous sclerosis (Bourneville-Pringle) |
415 |
-- |
Epidermolysis bullosa |
416 |
-- |
Pustular psoriasis |
417 |
-- |
Pemphigus |
418 |
-- |
Corticobasal degeneration |
419 |
-- |
Severe erythema multiforme (Acute Phase) |
420 |
-- |
Lymphangioleiomyomatosis (LAM) |
421 |
-- |
Fibrodysplasia Ossificans Progressiva (FOP) |
422 |
-- |
Xeroderma Pigmentosum (XP) |
423 |
-- |
Subacute Myelo-Optico-Neuropathy (SMON) |
424 |
-- |
Hypopituitarism |
425 |
-- |
Cushing syndrome |
426 |
-- |
-Cushing disease |
427 |
-- |
Acromegaly |
428 |
-- |
Primary lateral sclerosis |
429 |
-- |
Chorea with acanthocyte |
430 |
-- |
HTLV1-associated myelopathy (HAM) |
431 |
-- |
Congenital ichthyosiform erythroderma |
432 |
-- |
Angiitis |
433 |
-- |
-Microscopic polyAngitis |
434 |
-- |
-Wegener granulomatosis |
435 |
-- |
-Allergic Granulomatous Angitis (AGA) |
436 |
-- |
Immune complex vasculitis |
437 |
-- |
-Henoch?Schonlein purpura |
438 |
-- |
-Essential cryoglobulinemia |
439 |
-- |
-Malignant rheumatoid arthritis |
440 |
-- |
Hereditary angioedema |
441 |
-- |
Acquired angioedema |
442 |
-- |
Expect new drug/NOT make treatment decisions
Expect new drug |
-- |
NOT make treatment decisions |
-- |
Expect new drug |
-- |
NOT make treatment decisions |
-- |
Sales rep visit frequency
Visited in the last one month |
-- |
Asahikasei pharma |
-- |
Ajinomoto pharma |
-- |
Aska pharma |
-- |
Astellas pharma |
-- |
AstraZeneca |
-- |
Abbott Japan |
-- |
Eisai |
-- |
MSD (Banyu/Schering-Plough) |
-- |
Otsuka pharma |
-- |
Ono pharma |
-- |
Kaken pharma |
-- |
Kissei pharma |
-- |
Kyorin pharma |
-- |
Kyowa hakko kirin |
-- |
GlaxoSmithKline |
-- |
Kowa pharma |
-- |
Sawai pharma |
-- |
Santen Pharma |
-- |
Shionogi pharma |
-- |
Zeria pharma |
-- |
Sanofi-Aventis |
-- |
Daiichi Sankyo |
-- |
Taisho Toyama pharma |
-- |
Dainippon Sumitomo pharma |
-- |
Taiho pharma |
-- |
Teva Pharma |
-- |
Takeda pharma |
-- |
Mitsubishi Tanabe pharma |
-- |
Chugai pharma |
-- |
Tsumura |
-- |
Teijin pharma |
-- |
Towa pharma |
-- |
Torii pharma |
-- |
Nichi-Iko Pharma |
-- |
Alcon Japan |
-- |
Eli Lilly Japan |
-- |
Nippon Shinyaku |
-- |
Nippon Zoki |
-- |
Boehringer Ingelheim GmbH Japan |
-- |
Novartis pharma |
-- |
Novo Nordisk |
-- |
Bayer |
-- |
Hisamitsu Pharma |
-- |
Pfizer |
-- |
Bristol-Myers |
-- |
Mylan pharma |
-- |
Maruishi pharma |
-- |
Maruho |
-- |
Meiji Seika pharma |
-- |
Merck Serono |
-- |
Mochida pharma |
-- |
Janssen |
-- |
Other |
-- |
Asahikasei pharma - med |
-- |
Ajinomoto pharma - med |
-- |
Aska pharma - med |
-- |
Astellas pharma - med |
-- |
AstraZeneca - med |
-- |
Abbott Japan - med |
-- |
Eisai - med |
-- |
MSD (Banyu/Schering-Plough) - med |
-- |
Otsuka pharma - med |
-- |
Ono pharma - med |
-- |
Kaken pharma - med |
-- |
Kissei pharma - med |
-- |
Kyorin pharma - med |
-- |
Kyowa hakko kirin - med |
-- |
GlaxoSmithKline - med |
-- |
Kowa pharma - med |
-- |
Sawai pharma - med |
-- |
Santen Pharma - med |
-- |
Shionogi pharma - med |
-- |
Zeria pharma - med |
-- |
Sanofi-Aventis - med |
-- |
Daiichi Sankyo - med |
-- |
Taisho Toyama pharma - med |
-- |
Dainippon Sumitomo pharma - med |
-- |
Taiho pharma - med |
-- |
Teva Pharma - med |
-- |
Takeda pharma - med |
-- |
Mitsubishi Tanabe pharma - med |
-- |
Chugai pharma - med |
-- |
Tsumura - med |
-- |
Teijin pharma - med |
-- |
Towa pharma - med |
-- |
Torii pharma - med |
-- |
Nichi-Iko Pharma - med |
-- |
Alcon Japan - med |
-- |
Eli Lilly Japan - med |
-- |
Nippon Shinyaku - med |
-- |
Nippon Zoki - med |
-- |
Boehringer Ingelheim GmbH Japan - med |
-- |
Novartis pharma - med |
-- |
Novo Nordisk - med |
-- |
Bayer - med |
-- |
Hisamitsu Pharma - med |
-- |
Pfizer - med |
-- |
Bristol-Myers - med |
-- |
Mylan pharma - med |
-- |
Maruishi pharma - med |
-- |
Maruho - med |
-- |
Meiji Seika pharma - med |
-- |
Merck Serono - med |
-- |
Mochida pharma - med |
-- |
Janssen - med |
-- |
Other - med |
-- |
Respondent demography
Region |
-- |
# of Beds |
-- |
Facility |
-- |
DPC Hospital |
-- |
Regional cancer HP |
-- |